Form 4: KORU Medical Director Plans Share Purchase

KORU Medical Systems Director Edward Wholihan has a pre-planned acquisition of 3,916 shares of common stock at $3.83 per share, scheduled for October 2, 2025, which will increase his direct beneficial ownership to 41,688 shares.

Summary

• Edward Wholihan, a Director of KORU Medical Systems, Inc. (KRMD), is scheduled to acquire 3,916 shares of the company's common stock.
• The transaction is planned for October 2, 2025, at a price of $3.83 per share.
• This acquisition is being made pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Following this transaction, Mr. Wholihan will directly beneficially own a total of 41,688 shares of KORU Medical Systems common stock.

Sentiment

Score: 7

Explanation: The planned insider purchase by a director is a positive indicator of confidence in the company's future, although its impact is somewhat mitigated by being a pre-arranged 10b5-1 transaction rather than a discretionary open-market buy.

Positives

• The planned acquisition by a Director signals continued confidence in the company's future prospects and valuation.
• The transaction is part of a Rule 10b5-1 plan, indicating a long-term perspective on the investment.

Future Outlook

The filing itself does not provide a future outlook for the company, but the planned insider purchase suggests a positive long-term view from a company director.

Industry Context

Insider buying, particularly by a director, is generally viewed by the market as a positive signal, indicating management's belief in the company's intrinsic value and future performance. While this is a pre-planned transaction under Rule 10b5-1, it still reflects confidence at the time the plan was established.

Stakeholder Impact

• Shareholders may view this planned insider purchase as a positive signal, potentially reinforcing confidence in the company's stock.

Key Dates

Recommendation

While the planned insider purchase by a director is a positive signal of confidence, it is a pre-arranged transaction under a 10b5-1 plan and represents a relatively small increase in overall beneficial ownership. This reinforces a 'hold' position for investors who may already be invested or considering the stock, rather than a strong 'buy' signal based solely on this filing.

Keywords

KORU Medical Systems, KRMD, Edward Wholihan, Insider Trading, Stock Acquisition, Director Purchase, Common Stock, 10b5-1 Plan